Choriocarcinoma developed from a complete hydatidiform mole has an uni
que genetic feature that involves monoallelic contribution from the pa
ternal genome, To the chromosome carrying putative tumor gene(s), micr
ocell-hybrids were isolated following fusion of choriocarcinoma cells
with microcells from mouse A9 cells containing a single human chromoso
me (1, 2, 6, 7, 9 or 11), Microcell-hybrids with the introduction of c
hromosome 7 were suppressed or modulated for tumorigenicity and exhibi
ted altered in vitro growth properties, Introduction of chromosomes 1,
2, 6, 9 or 11 had no effect, Tumorigenic revertants isolated from mic
rocell-hybrids with the introduced chromosome 7 contains reduced numbe
rs of chromosome 7, These findings suggest that chromosome 7 contains
a putative tumor suppressor gene(s) for choriocarcinoma, Alterations i
n tumorigenic phenotypes seen in microcell-hybrids were not associated
with the presence of either ERV3 or H-plk locus located on the introd
uced chromosome 7, indicating the putative tumor suppressor gene(s) is
outside of ERV3 and H-plk gene loci, Furthermore, we obtained evidenc
e to define a critical region on chromosome 7 (7p12-7q11.23) that was
frequently lost in surgically removed choriocarcinoma tissues and cell
lines, Using a panel of microsatellite markers, biallelic deletions w
ere observed, which strongly suggests the presence of a tumor suppress
or gene(s) within this critical region.